陶氏化学和杜邦公司关于欧盟委员会启动第二阶段审查的声明

2016年8月11日—美国特拉华州威明顿、密歇根州米德兰讯——杜邦公司(纽约证交所代码:DD)和陶氏化学公司(纽约证交所代码:DOW)于今日确定欧盟委员会(EC)已经针对两家公司的平等合并交易启动了第二阶段审查。如先前所述,两家公司预计会受到这次全面的审查,正与包括欧盟委员会在内的相关监管部门密切合作。杜邦公司与陶氏化学公司依旧确信此次合并将促进竞争,令客户和消费者受益。

根据《欧盟并购条例》,在针对这样大小及范围的交易的审查过程中,启动第二阶段审查是很常见的程序。在该条例下,委员会通常将有90个工作日来对待定的交易进行第二阶段审查。陶氏化学公司和杜邦公司将继续与委员会展开具有建设性的合作,以解决委员会的顾虑,我们相信会获得批准实现合并。

6月22日,杜邦公司和陶氏化学公司提交了与申请所拟平等合并相关所需的备案,启动申请欧盟委员会批准合并的正式流程。陶氏化学公司和杜邦公司仍旧预计此次合并交易将于2016年底完成,这将取决于是否满足惯例成交条件,包括获得监管部门批准等。

了解更多信息,请浏览www.dowdupontunlockingvalue.com.

关于陶氏化学公司

陶氏(NYSE: DOW)运用科学和技术的力量,不断创新,为人类创造更美好的生活。陶氏通过材料、聚合物、化学和生物科学,来推动创新和创造价值,全力解决当今世界的诸多挑战,如满足清洁水的需求、实现清洁能源的生产和节约、提高农作物产量等。陶氏以其一体化、市场驱动型、行业领先的特种化学、高新材料、农业科学和塑料等业务,为全球约180个国家和地区的客户提供种类繁多的产品及服务,应用于包装、电子产品、水处理、涂料和农业等高速发展的市场。2015年,陶氏年销售额为近490亿美元,在全球拥有约49,500名员工,在35个国家和地区运营179家工厂,产品系列达6,000多种。2016年6月1日起,陶氏将拥有道康宁公司100%的股权。道康宁2015年销售额超过45亿美元,在全球拥有约10,000名员工,在9个国家和地区运营25家工厂。除特别注明外,“陶氏”或“公司”均指陶氏化学公司及其关联公司。有关陶氏的进一步资料,请浏览陶氏网页:www.dow.com

关于杜邦公司

创立于1802年的杜邦公司(纽约证交所代码:DD)凭借创新的产品、材料和服务,为全球市场提供世界级的科学和工程能力。杜邦公司相信,通过与客户、政府机构、非政府组织和思想领袖开展协作,我们协助提供应对各种全球性挑战的解决方案,包括为全球各地的人们提供充足健康的食物、减少对化石燃料的依赖,以及保护生命与环境。请登陆杜邦公司网站www.dupont.com,了解更多公司信息以及杜邦对包容性创新的承诺。

 

联系信息:

陶氏化学联络人 杜邦公司联络人
   
投资者关系 投资者关系
Neal Sheorey Greg Friedman
nrsheorey@dow.com greg.friedman@dupont.com
+1 989-636-6347 +1 302-774-4994
媒体关系 媒体关系
Rachelle Schikorra Dan Turner
ryschikorra@dow.com daniel.a.turner@dupont.com
+1 989-638-4090 +1 302-996-8372

Cautionary Notes on Forward Looking Statements

This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. These and other forward-looking statements, including the failure to consummate the proposed transaction or to make or take any filing or other action required to consummate such transaction on a timely matter or at all, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to, (i) the completion of the proposed transaction on anticipated terms and timing, including obtaining regulatory approvals, anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the new combined company’s operations and other conditions to the completion of the merger, (ii) the ability of Dow and DuPont to integrate the business successfully and to achieve anticipated synergies, risks and costs and pursuit and/or implementation of the potential separations, including anticipated timing, any changes to the configuration of businesses included in the potential separation if implemented, (iii) the intended separation of the agriculture, material science and specialty products businesses of the combined company post-mergers in one or more tax efficient transactions on anticipated terms and timing, including a number of conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances, disruptions in the financial markets or other potential barriers, (iv) potential litigation relating to the proposed transaction that could be instituted against Dow, DuPont or their respective directors, (v) the risk that disruptions from the proposed transaction will harm Dow’s or DuPont’s business, including current plans and operations, (vi) the ability of Dow or DuPont to retain and hire key personnel, (vii) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the merger, (viii) uncertainty as to the long-term value of DowDuPont common stock, (ix) continued availability of capital and financing and rating agency actions, (x) legislative, regulatory and economic developments, (xi) potential business uncertainty, including changes to existing business relationships, during the pendency of the merger that could affect Dow’s and/or DuPont’s financial performance, (xii) certain restrictions during the pendency of the merger that may impact Dow’s or DuPont’s ability to pursue certain business opportunities or strategic transactions and (xiii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors. These risks, as well as other risks associated with the proposed merger, are more fully discussed in the joint proxy statement/prospectus included in the Registration Statement filed with the SEC in connection with the proposed merger. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Dow’s or DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. Neither Dow nor DuPont assumes any obligation to publicly provide revisions or updates to any forward looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.